← Back to all signals
RESEARCH PAPER ANALYSIS

Timing of breast cancer diagnosis postpartum and survival in women with germline pathogenic variants.

AI interpretation is pending for this paper.

Open original publication →
PMID42659893
JournalESMO open
Publication Date2026-08-27
Ingested2026-08-29 09:15 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: Parity and breastfeeding reduce lifetime breast cancer (BC) risk, but the postpartum period is associated with transiently increased risk and poor outcomes. The prognostic significance of reproductive timing in women with germline pathogenic susceptibility variants (PVs) remains unclear. We evaluated the association between time since last childbirth, breastfeeding, and other reproductive variables and overall survival (OS) in a large Australian hereditary BC cohort. PATIENTS AND METHODS: We conducted a retrospective cohort study of 1200 female PV carriers with invasive BC enrolled in the Kathleen Cuningham Foundation Consortium (1980-2022). Eligible participants carried class 4-5 PVs in high- or moderate-penetrance BC susceptibility genes and had no pregnancies after BC diagnosis. Time since last childbirth was categorised as nulliparous, <10 years, or ≥10 years, with further analyses using five postpartum intervals. Cox proportional hazards models, adjusted for age, oestrogen receptor (ER) status, chemotherapy, surgery, and radiotherapy, were used to assess associations with OS. RESULTS: Of 1200 women (median follow-up, 13 years), 52% were diagnosed ≥10 years postpartum, 32% were diagnosed <10 years, and 16% were nulliparous. Women diagnosed <10 years postpartum were younger (median 36 compared with 48 years, P < 0.001), more likely to carry BRCA1 PVs, and had more ER-negative disease. Diagnosis ≥10 years postpartum was associated with improved OS compared with nulliparity [hazard ratio (HR) 0.63, 95% confidence interval (CI) 0.43-0.92, P = 0.02]. In parous women, breastfeeding compared with no breastfeeding (HR 0.49, 95% CI 0.33-0.73, P < 0.001) and diagnosis ≥10 vs <10 years since last childbirth (HR 0.48, 95% CI 0.31-0.74, P < 0.001) independently predicted better OS. CONCLUSIONS: In women with PVs, longer time since last childbirth and breastfeeding were independently associated with improved survival following BC diagnosis. These findings identify reproductive timing and lactation as important prognostic modifiers in hereditary BC and may inform risk stratification and survivorship care.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 The Journey with paediatric cancer: reflections on its impact on patients and their families. The Pan African medical journal 56.0 2 Pars plana vitrectomy in uveitis of diverse etiologies: indications and surgical outcomes. BMC ophthalmology 63.5 3 Persistent Oropharyngeal Hemangioma Causing Progressive Upper Airway Compromise: Diagnostic and Therapeutic Challenges. Cureus 61.64 4 Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment, and follow-up of patients with hepatocellular carcinoma. ESMO open 71.84 5 Life Saving Hepatic Resections in Ruptured Pediatric Hepatoblastoma - a Report of 3 Cases. Indian journal of surgical oncology 63.6 6 Development and Internal Validation of the SPR-HCC Score System: A Prognostic Tool for Survival Prediction in Hepatocellular Carcinoma in a Resource-Limited Setting. Asian Pacific journal of cancer prevention : APJCP 72.02 7 Retinoblastoma Incidence in Saudi Arabia: A 20-Year Analysis. Asian Pacific journal of cancer prevention : APJCP 57.5 8 Systemic Immune Inflammation Index as High-Risk Retinoblastoma Survival Predictor. Asian Pacific journal of cancer prevention : APJCP 63.12 9 Predictors of Cervical Cancer Screening Uptake Among Women of Reproductive Age in Indonesia: A Nationwide Cross-Sectional Study Based on the 2023 Indonesian Health Survey. Asian Pacific journal of cancer prevention : APJCP 67.5 10 Effects of estetrol/drospirenone vs drospirenone-only on thrombin generation in women with polycystic ovary syndrome: a randomized, double-blind, controlled trial. Research and practice in thrombosis and haemostasis 77.6 11 Quality indicators for the care of children with CNS tumors: An international modified Delphi study. Neuro-oncology advances 72.0 12 Feasibility, uptake, and exploratory outcomes of an individualized exercise program in pediatric oncology: a prospective single-center pilot study. Frontiers in pediatrics 64.1 13 Prenatal diagnosis and outcomes of fetal cardiac tumors: a 10-year single-center study of 81 cases. Frontiers in medicine 66.0 14 Advances in the association between tumor immune microenvironment remodeling in osteosarcoma and the risk of pathological fractures. Frontiers in genetics 54.3 15 Proximal Phalanx Enchondroma in a Pediatric Patient: Curettage, Liquid Nitrogen Cryotherapy, Iliac Crest Autograft, and Microfragment Plate Fixation. Cureus 61.64 16 Beyond size: the role of growth rate in managing adolescent breast masses. American journal of surgery 68.5 17 Primary ovarian non-small cell neuroendocrine carcinoma in an adolescent: The youngest case reported to date. Pathology, research and practice 45.5 18 Indocyanine Green (ICG) fluorescence-Guided Surgery (FGS) in pediatric Wilms tumor: Opportunities and Challenges. Surgical oncology 47.5 19 Targeting SUV4-20H2-mediated H4K20 methylation restrains growth and migration in pediatric high-grade astrocytomas. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 62.2 20 Myxoid Pleomorphic Liposarcoma: A Clinicopathological and Cytogenomic Study of 24 Cases. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 60.7 21 Astragaloside IV is associated with TFRC-dependent ferroptosis and JAK2/STAT3 pathway inhibition in osteosarcoma cells. Biochimica et biophysica acta. General subjects 68.5 22 Purely osteolytic bone lesions in the early osteoarticular phase of synovitis, acne, pustulosis, hyperostosis and osteitis syndrome. BMJ case reports 54.0 23 Spatial Lineage Divergence at Diagnosis in a Pediatric KMT2A-Rearranged Leukemia Presenting with Concurrent AML and B-LBL. Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 53.9 24 Temporary Perineal Urethrostomy for Bladder Tumor Resection. Case reports in urology 45.5 25 Public support for policies to create a healthier food environment in Aotearoa New Zealand: findings from a national survey. The New Zealand medical journal 65.2 26 The public in Aotearoa New Zealand support policies to reduce alcohol harm: results from a national survey. The New Zealand medical journal 66.5 27 Public support for government-led skin cancer prevention in Aotearoa New Zealand: findings from a national survey. The New Zealand medical journal 66.6 28 Public support for better controls on lobbying and industry influence in Aotearoa New Zealand: findings from a national survey. The New Zealand medical journal 43.2 29 Aotearoa New Zealanders' views of policies and funding for human papillomavirus vaccination and screening for cervical and lung cancers: a national survey. The New Zealand medical journal 66.4 30 Aotearoa New Zealand public strongly support investment in cancer treatment and care services: findings from a national survey. The New Zealand medical journal 66.94 31 Public support for cancer prevention and care policies in Aotearoa New Zealand: methods of a national survey. The New Zealand medical journal 66.9 32 Myocardial Fibrosis in Pediatric Heart Disease: Mechanisms, Imaging Biomarkers, Clinical Consequences, and Emerging Antifibrotic Therapies. Cardiology in review 63.9
PATIENT-FRIENDLY SUMMARY

Timing of breast cancer diagnosis postpartum and survival in women with germline pathogenic variants.

For education only—not personal medical advice.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic